News

September 18, 2019September 18, 2019

Bryostatin-1 Fails to Ease Dementia in Moderate-to-Severe Alzheimer’s Patients in Phase 2 Trial

News

An investigational Alzheimer’s treatment called bryostatin-1 failed to meet its primary goal — lesser evidence of dementia in people with more severe disease — in a Phase 2 clinical ... Read more

September 17, 2019

FTC Warns Companies Against Unsubstantiated Advertising of CBD Products for Fibromyalgia

News

The U.S. Federal Trade Commission (FTC) sent warning letters to three companies that sell cannabis-based products containing cannabidiol (CBD), cautioning them that making unsubstantiated claims about the health benefits ... Read more

September 16, 2019September 16, 2019

PTI-125 Reduces Neurodegeneration After 28 Days of Treatment, Data Show

News

PTI-125, Cassava Sciences’ lead therapeutic candidate for the treatment of Alzheimer’s disease, significantly reduced the levels of disease biomarkers, brain inflammation, and neurodegeneration after 28 days of treatment, top-line ... Read more

September 13, 2019September 13, 2019

ADvance II Study Testing Deep Brain Stimulation in Mild Alzheimer’s Started, Enrollment Ongoing

News

The first patient enrolled in the ADvance II Study has been implanted with a deep brain stimulation (DBS) device to start treatment for mild Alzheimer’s disease. The study will ... Read more

September 11, 2019September 11, 2019

Diet Directly Affects Gut Bacteria and May Contribute to Alzheimer’s Progression, Pilot Study Suggests

News

A modified Mediterranean-ketogenic diet can regulate bacteria in the gut that may contribute to the development and progression of cognitive impairment and Alzheimer’s disease, results from a pilot study ... Read more

September 9, 2019September 9, 2019

ARPF Set to Host Brain Longevity Therapy Training and Symposium

News

With the goal of warding off Alzheimer’s disease through integrative medicine, the Alzheimer’s Research and Prevention Foundation (ARPF) will host its third Brain Longevity Therapy Training and Symposium Oct. 24-27 ... Read more

September 6, 2019September 6, 2019

TREM2 Protein May Slow Memory Impairment in Alzheimer’s, Study Suggests

News

Higher concentrations of a protein produced exclusively by the brain’s immune cells, called TREM2, may prevent memory decline and lessen brain degeneration in people with Alzheimer’s disease, according to ... Read more

September 4, 2019September 4, 2019

ATXN1 Gene Tied to Rare Disorder Regulates Key Enzyme in Alzheimer’s

News

A gene associated with a rare balance disorder also may be involved in susceptibility to Alzheimer’s disease, a new study in mice shows. The study, “Loss of Ataxin-1 Potentiates ... Read more

August 30, 2019August 30, 2019

3D Model Unravels How Beta-amyloid Weakens Brain-Blood Barrier, May Aid in Treatment Discovery

News

A new 3D model using human cells grown on a chip can mimic what happens in the brain during Alzheimer’s and allow for the screening of possible therapies in ... Read more

August 28, 2019August 28, 2019

Understanding Protein Aggregation May Aid Quest for Better Alzheimer’s Treatments

News

Better understanding the mathematics behind how protein clumps form — and how therapies interfere with this process — may improve treatment strategies for Alzheimer’s, and other diseases, new research ... Read more

Pin It on Pinterest